文献速递慢阻肺呼吸道感染

COPD急性加重期痰微生物组时间变异与菌群失调:COPDMAP研究分析

Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
PubMed 文献 · Thorax · 2017-12-21

该研究对281名COPD患者纵向采集的716份痰标本行16S rRNA微生物组检测,发现41%的急性加重存在菌群失调,且菌群失调与FEV1和FVC下降更大、CAT评分升高更多相关,尤其在合并嗜酸性炎症的加重中。

要点

  • 41%的COPD急性加重存在痰菌群失调,即微生物组成相对基线的显著个体内偏离。
  • 菌群失调与急性加重更严重相关:FEV1和FVC下降更大、CAT评分升高更多。
  • 菌群失调合并嗜酸性气道炎症时,肺功能下降更明显。

核心结论

  • 微生物菌群失调是部分COPD急性加重的特征,尤其合并嗜酸性炎症时与更严重的肺功能下降相关。

研究设计与样本

  • 对281名COPD患者纵向采集的716份痰标本(基线与急性加重期)行16S rRNA微生物组检测,来自英国三个临床中心,为COPDMAP联盟研究。

主要发现

  • 微生物组成在各中心间及稳定期与急性加重期之间相似,仅急性加重期Veillonella有小幅显著减少。
  • Moraxella丰度与细菌alpha多样性呈负相关。
  • 细菌相关急性加重与嗜酸性气道炎症相关急性加重的微生物组不同。
  • 41%的急性加重存在菌群失调(微生物组成相对基线的显著个体内偏离)。
  • 菌群失调与急性加重更严重相关:FEV1和FVC下降更大、CAT评分升高更多,尤其在合并嗜酸性炎症的加重中。

临床怎么用

  • 对COPD急性加重患者可关注痰菌群失调状态,尤其合并嗜酸性炎症时提示肺功能下降风险更高。

局限性

  • 微生物alpha和beta多样性时间变异在各中心间存在显著差异,可能影响结果的可推广性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies suggest that lung microbiome dysbiosis, the disease associated disruption of the lung microbial community, might play a key role in chronic obstructive pulmonary disease (COPD) exacerbations. However, characterising temporal variability of the microbiome from large longitudinal COPD cohorts is needed to better understand this phenomenon. METHODS: We performed a 16S ribosomal RNA survey of microbiome on 716 sputum samples collected longitudinally at baseline and exacerbations from 281 subjects with COPD at three UK clinical centres as part of the COPDMAP consortium. RESULTS: The microbiome composition was similar among centres and between stable and exacerbations except for a small significant decrease of Veillonella at exacerbations. The abundance of Moraxella was negatively associated with bacterial alpha diversity. Microbiomes were distinct between exacerbations associated with bacteria versus eosinophilic airway inflammation. Dysbiosis at exacerbations, measured as significant within subject deviation of microbial composition relative to baseline, was present in 41% of exacerbations. Dysbiosis was associated with increased exacerbation severity indicated by a greater fall in forced expiratory volume in one second, forced vital capacity and a greater increase in CAT score, particularly in exacerbations with concurrent eosinophilic inflammation. There was a significant difference of temporal variability of microbial alpha and beta diversity among centres. The variation of beta diversity significantly decreased in those subjects with frequent historical exacerbations. CONCLUSIONS: Microbial dysbiosis is a feature of some exacerbations and its presence, especially in concert with eosinophilic inflammation, is associated with more severe exacerbations indicated by a greater fall in lung function. TRIAL REGISTRATION NUMBER: Results, NCT01620645.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Wang Z, Singh R, Miller BE, et al. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study. Thorax. 2017. PMID: 29269441. doi:10.1136/thoraxjnl-2017-210741

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。